New clinic aims to tackle muscle wasting in COPD patients

NCT ID NCT07059637

Recruiting now Disease control Sponsor: The Cleveland Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a specialized clinic designed to diagnose and treat muscle loss (sarcopenia) in people with COPD. The clinic brings together a team of experts to provide targeted care. Researchers will see if this approach improves muscle mass and function, and reduces hospitalizations and COPD flare-ups compared to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: multidisciplinary clinic evaluation
What this could lead to: If successful, this clinic could become a standard way to diagnose and treat muscle loss in COPD patients, potentially reducing hospital stays and improving quality of life.
What could go wrong: This is a small, early-stage study with only 80 participants, so results may not apply to all COPD patients. The clinic approach may not prove better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset pulmonary emphysema Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD EMPHYSEMA SARCOPENIA

Contacts and locations

Locations

Cleveland Clinic Foundation
RECRUITING

Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.